1. Home
  2. GLU vs STIM Comparison

GLU vs STIM Comparison

Compare GLU & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gabelli Global Utility of Beneficial Ownership

GLU

Gabelli Global Utility of Beneficial Ownership

HOLD

Current Price

$18.50

Market Cap

110.5M

Sector

Finance

ML Signal

HOLD

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.48

Market Cap

104.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLU
STIM
Founded
2004
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.5M
104.1M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
GLU
STIM
Price
$18.50
$1.48
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
12.4K
1.5M
Earning Date
01-01-0001
11-04-2025
Dividend Yield
8.60%
N/A
EPS Growth
N/A
N/A
EPS
0.62
N/A
Revenue
N/A
$129,873,000.00
Revenue This Year
N/A
$101.67
Revenue Next Year
N/A
$10.87
P/E Ratio
$22.50
N/A
Revenue Growth
N/A
78.61
52 Week Low
$11.61
$1.10
52 Week High
$15.40
$5.92

Technical Indicators

Market Signals
Indicator
GLU
STIM
Relative Strength Index (RSI) 58.15 42.54
Support Level $18.36 $1.28
Resistance Level $18.65 $1.79
Average True Range (ATR) 0.19 0.15
MACD 0.01 0.07
Stochastic Oscillator 73.42 40.00

Price Performance

Historical Comparison
GLU
STIM

About GLU Gabelli Global Utility of Beneficial Ownership

Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: